商湯早盤再次大漲20%,市值已達3100億
uSMART盈立智投 | 商湯(00020)上市第四個交易日繼續維持強勢,早盤高開高走,盤中大漲20%,報9.44元,成交額5.86億元,最新市值逼近3100億港元。
若以現價計,該股已較招股價3.85元漲1.45倍,一手賬面可賺近5000元。
商湯是一家專注於計算機視覺軟件的人工智能軟件公司,業務涵蓋智慧商業、智慧城市、智慧生活、智能汽車四大板塊。
根據沙利文報告,公司收入已在2020年位列行業亞洲第一。數據顯示,2018年-2020年和2021年上半年,公司營業收入分別爲18.5億元、30.3億元、34.5億元和16.5億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.